Physician
Ahmed, Farooq
Ahmed, Farooq was paid $2.67M by Medicaid between Jan 2018 and Dec 2024, across 84 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 18% of everything it billed.
33Billing provider infoAHMED, FAROOQ
SKOKIE, IL 60077
SKOKIE, IL 60077
33aNPI1275553240assigned 07/20/2006
33bProvider typeAdolescent Medicine (Family Medicine) Physician
28Total paid$2.67M
24GClaims93,742
24DCodes billed84
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Adolescent Medicine (Family Medicine) Physician providers in Illinois
Rank by total paid#1 of 6
Median peer was paid$107K
This provider vs. median25×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 9,409 | $276K | |
| 2019 | 16,600 | $459K | |
| 2020 | 14,416 | $403K | |
| 2021 | 20,405 | $592K | |
| 2022 | 17,470 | $544K | |
| 2023 | 9,489 | $251K | |
| 2024incomplete | 5,953 | $149K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 18% | 10,335 | 8,060 | $484K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 10% | 4,030 | 3,017 | $280K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 6.5% | 3,791 | 3,346 | $174K |
| 99243 | 6.5% | 1,766 | 1,531 | $172K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 4.6% | 1,594 | 1,245 | $124K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 3.9% | 2,979 | 2,271 | $105K |
| 99349 | 3.0% | 4,638 | 4,559 | $79K | |
| 96160 | 2.9% | 5,397 | 4,252 | $77K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 2.8% | 1,698 | 1,349 | $76K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 2.7% | 1,014 | 819 | $72K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 2.6% | 1,557 | 1,257 | $69K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 2.5% | 1,530 | 1,251 | $68K |
72 more codes
| 99204 | Doctor's office visit, new patient (more involved) | 2.3% | 787 | $60K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 1.9% | 1,797 | $50K |
| 99337 | 1.5% | 2,355 | $41K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1.4% | 1,613 | $38K |
| 86696 | 1.4% | 969 | $37K | |
| 87186 | 1.4% | 1,120 | $36K | |
| 96127 | 1.3% | 2,411 | $35K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 1.2% | 295 | $33K |
| 99401 | 1.2% | 1,128 | $31K | |
| 87428 | 1.1% | 480 | $30K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.1% | 1,417 | $29K |
| 94760 | 1.1% | 7,117 | $28K | |
| 86695 | 1.1% | 988 | $28K | |
| 99244 | Office or other outpatient consultation, moderate to high complexity | 1.1% | 191 | $28K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,692 | $26K |
| 99348 | <1% | 859 | $20K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 272 | $19K |
| 99384 | <1% | 182 | $18K | |
| 87088 | <1% | 1,660 | $18K | |
| 86803 | <1% | 1,020 | $17K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,684 | $17K |
| 87481 | <1% | 272 | $17K | |
| 87503 | <1% | 892 | $16K | |
| 87070 | <1% | 2,450 | $15K | |
| 86704 | <1% | 929 | $14K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 167 | $14K |
| 86706 | <1% | 965 | $13K | |
| 99383 | <1% | 146 | $13K | |
| 99336 | <1% | 695 | $12K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 2,103 | $12K |
| 81001 | <1% | 4,107 | $12K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 192 | $10K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 303 | $8K |
| 80053 | Comprehensive metabolic panel | <1% | 657 | $7K |
| 94010 | <1% | 189 | $7K | |
| 92551 | <1% | 429 | $6K | |
| 87510 | <1% | 258 | $6K | |
| 81002 | <1% | 2,469 | $6K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 82 | $6K |
| 99385 | <1% | 59 | $6K | |
| 86592 | <1% | 1,295 | $5K | |
| 87340 | <1% | 372 | $5K | |
| 99070 | <1% | 221 | $5K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 60 | $5K |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | <1% | 151 | $5K |
| 86780 | <1% | 215 | $4K | |
| 81025 | <1% | 806 | $3K | |
| 90715 | <1% | 167 | $3K | |
| 90734 | <1% | 173 | $2K | |
| 86705 | <1% | 154 | $2K | |
| 99173 | <1% | 288 | $2K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 209 | $2K |
| 80074 | <1% | 47 | $2K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 50 | $2K |
| 86694 | <1% | 122 | $2K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 78 | $1K |
| 83026 | <1% | 438 | $1K | |
| 85018 | <1% | 406 | $934.49 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 117 | $730.80 |
| 99344 | <1% | 14 | $609.64 | |
| 86709 | <1% | 99 | $603.75 | |
| 99327 | <1% | 13 | $450.54 | |
| 90649 | <1% | 31 | $446.69 | |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care | <1% | 79 | $420.69 |
| 86707 | <1% | 26 | $238.49 | |
| 90710 | <1% | 35 | $224.00 | |
| 82962 | <1% | 119 | $207.13 | |
| 90713 | <1% | 28 | $179.20 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 23 | $82.00 |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | <1% | 20 | $38.34 |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 0% | 96 | $0.00 |
| 90461 | 0% | 60 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.